64:, providing critical windows of insight into the market and competition. Through such monitoring, MSLs can gain access to key influencers by interacting with national and regional societies and organizations. Moreover, as MSLs specialize in a particular therapeutic area and have scientific knowledge related to it. The educational background of MSLs consists primarily of MDs, DMSc, PharmD, and PhD professionals. Other professions who work as MSLs include Physician Assistants and Nurses. According to the program's advocates, the Board Certified Medical Affairs Specialist (BCMAS) program is the recognized MSL board certification for MSL professionals. They are now highly involved in activities related to
43:
as "Education services – namely, initiation of drug studies in laboratory and clinical settings and development of workshops, symposia, and seminars for physicians, medical societies, specialty organizations, academicians, in concert, concerned with drug related medical topics" in 1967 and with first
47:
As the number of MSL programs in healthcare increased, subsequent peer-reviewed journal publications and books became available to examine the emerging role of medical affairs and the use of MSLs in an increasingly vertically integrated biotechnology industry.
36:, medical device, and managed care companies. Other job titles for medical science liaisons may include medical liaisons, clinical science liaisons, medical science managers, regional medical scientists, and regional medical directors.
152:
Malecha, S. E.; Wiejowski, S. A. & Holt, R. J. (2000). "The applied therapeutics team: an innovative model of drug information in the pharmaceutical industry".
234:
281:
179:
Wolin, M. J.; Ayers, P. M. & Chan, E. K. (2001). "The emerging role of medical affairs within the modern pharmaceutical company".
98:
Providing medical review to ensure all company materials are compliant and accurately reflect the body of scientific evidence
276:
116:
76:
The medical science liaison role is varied and day-to-day activities include (but are not limited to);
121:
235:"Medical Affairs and Medical Science Liaison (MSL) Board Certification: A Comprehensive Review"
61:
8:
206:
Chin, J. (2004). "Biotechnology's special forces: field-based medical science liaisons".
140:
111:
215:
188:
161:
219:
192:
165:
65:
57:
29:
270:
33:
151:
25:
101:
Delivering insights from KOLs to inform the medical affairs strategy
178:
258:
141:
United States Patent and
Trademark Office Serial Number 73176757
40:
92:
Maintaining a high level of therapeutic area knowledge
56:
MSLs build relationships with key opinion leaders or
268:
86:Developing collaborative relationships with KOLs
39:The term "MSL" was originally trademarked by
28:consulting professional who is employed by
232:
205:
80:Managing investigator initiated studies
282:Promotion and marketing communications
269:
71:
13:
83:Performing KOL stakeholder mapping
14:
293:
233:Bouilloux, Eric (June 10, 2020).
252:
226:
199:
172:
145:
134:
95:Training sales representatives
1:
127:
220:10.1057/palgrave.jcb.3040088
117:Pharmaceutical manufacturing
7:
105:
10:
298:
193:10.1177/009286150103500225
166:10.1177/009286150003400411
89:Organising advisory boards
44:use in commerce in 1967.
239:Pharmaceutical Executive
122:Pharmaceutical marketing
277:Pharmaceutical industry
51:
18:medical science liaison
259:www.mslconsultant.com
208:J. Commer. Biotechnol
62:health care providers
112:Biopharmaceutical
289:
261:
256:
250:
249:
247:
245:
230:
224:
223:
203:
197:
196:
176:
170:
169:
160:(4): 1069–1075.
149:
143:
138:
72:Responsibilities
297:
296:
292:
291:
290:
288:
287:
286:
267:
266:
265:
264:
257:
253:
243:
241:
231:
227:
204:
200:
177:
173:
150:
146:
139:
135:
130:
108:
74:
66:clinical trials
58:thought leaders
54:
12:
11:
5:
295:
285:
284:
279:
263:
262:
251:
225:
198:
187:(2): 547–555.
181:Drug Inform. J
171:
154:Drug Inform. J
144:
132:
131:
129:
126:
125:
124:
119:
114:
107:
104:
103:
102:
99:
96:
93:
90:
87:
84:
81:
73:
70:
53:
50:
30:pharmaceutical
9:
6:
4:
3:
2:
294:
283:
280:
278:
275:
274:
272:
260:
255:
244:September 25,
240:
236:
229:
221:
217:
213:
209:
202:
194:
190:
186:
182:
175:
167:
163:
159:
155:
148:
142:
137:
133:
123:
120:
118:
115:
113:
110:
109:
100:
97:
94:
91:
88:
85:
82:
79:
78:
77:
69:
67:
63:
59:
49:
45:
42:
37:
35:
34:biotechnology
31:
27:
23:
19:
254:
242:. Retrieved
238:
228:
211:
207:
201:
184:
180:
174:
157:
153:
147:
136:
75:
55:
46:
38:
21:
17:
15:
271:Categories
214:(4): 1–7.
128:References
26:healthcare
106:See also
24:) is a
41:Upjohn
246:2021
60:and
52:Role
216:doi
189:doi
162:doi
22:MSL
273::
237:.
212:10
210:.
185:35
183:.
158:34
156:.
68:.
32:,
16:A
248:.
222:.
218::
195:.
191::
168:.
164::
20:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.